| Name | Title | Contact Details |
|---|
PrimeMyBody is a global company that helps people to live wellness and create lifestyle. We formulate life-changing products with quality in mind, and that means using nothing but the best nature has to offer. Being healthy isn`t a fad or a trend... instead, it`s a lifestyle, and our goal is to show the world just that.
Central Massachusetts Independent Physician Association is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With nearly 5,000 employees comprising Acadian Ambulance, Acadian Air Med, National EMS Academy, Acadian Total Security, Safety Management Systems and Executive Aircraft Charter Service, Acadian Companies provides a diverse suite of services that offer the very best support and education in health, safety and transportation.
Youth Alternatives Ingraham is a South Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.